Home Cart Sign in  
Chemical Structure| 1059734-66-5 Chemical Structure| 1059734-66-5

Structure of BMS-833923
CAS No.: 1059734-66-5

Chemical Structure| 1059734-66-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-833923 is an inhibitor of Smoothened with potential antineoplastic activity. It can also inhibit BODIPY cyclopamine binding to SMO with IC50 of 21 nM.

Synonyms: XL-139

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-833923

CAS No. :1059734-66-5
Formula : C30H27N5O
M.W : 473.57
SMILES Code : O=C(NC1=CC(CNC)=CC=C1C)C2=CC=C(NC3=NC(C4=CC=CC=C4)=C5C=CC=CC5=N3)C=C2
Synonyms :
XL-139
MDL No. :MFCD25976660
InChI Key :KLRRGBHZCJLIEL-UHFFFAOYSA-N
Pubchem ID :57662985

Safety of BMS-833923

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of BMS-833923

Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
AB3T cells 1 µM 72 h Evaluate the inhibitory effect of BMS-833923 on AB cells with SMO-L412F mutation, showing significant reduction in cell viability and Hedgehog pathway signaling. J Dent Res. 2022 Nov;101(12):1517-1525
human bone marrow mesenchymal stem cells (hMSC-TERT) 3μM 10 days To evaluate the effect of BMS-833923 on osteogenic differentiation of hMSCs, results showed decreased ALP activity, reduced mineralization capacity, and downregulation of osteoblast-related gene expression. Stem Cells Int. 2019 Nov 21;2019:3435901

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Salamander Axolotl larvae Solution treatment 1 μg/ml 10 days Inhibited proximodistal outgrowth of the limb bud in axolotl embryos, significantly downregulated expression of Ptch1, Grem1, and Fgf8 Front Cell Dev Biol. 2022 Apr 1;10:797352
C57BL6/NCrl mice Depilated mouse model Topical application 2% (w/v) Single application, lasting 8 hours To evaluate the inhibitory effect of BMS-833923 on Gli1 and Ptch1 mRNA expression in the skin of depilated mice after topical application. Results showed that BMS-833923 was ineffective in this model. Pharmacol Res Perspect. 2016 Mar 4;4(2):e00214
Zebrafish Juvenile zebrafish Water bath 0.63-1.25 μM From 21 dpf to 42 dpf, treated for 4 hours every other day Inhibition of Shh/Smo signaling prevents ray branching in all fins (paired and unpaired) with minimal effects on initial skeletal patterning, ray outgrowth or bone differentiation Dev Biol. 2021 Sep;477:177-190

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02100371 Basal Cell Nevus Syndrome COMPLETED 2025-05-17 Princess Margaret Cancer Centr... More >>e, Toronto, Ontario, M5G 2M9, Canada Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.56mL

2.11mL

1.06mL

21.12mL

4.22mL

2.11mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories